Scaling Non-Viral Cell Therapy Approaches for Solid Tumor Treatments

In this webinar, scientists from PACT Pharma Inc. and Thermo Fisher Scientific discuss how scalable, closed instruments can enable automation and standardization of the end-to-end manufacturing workflow—from cell isolation and activation to genetic modification and expansion.

Scaling and automating the cell therapy manufacturing process
Safety and regulatory advantages of non-viral transfection for cell therapy
A highly efficient non-viral precision genome engineering process to manufacture personalized cell therapies for solid tumors

Fill out the form below to watch the webinar

First Name*

Last Name*

Email*

Work Phone Number*

Company Name*

Job Title*

Zip Code*

Country*

What cell type are you working on?*

What is your purchase timeline?*

consent

I agree for the Thermo Fisher Scientific group to contact me by e-mail and telephone to inform me of events, products, services and promotions offered in connection with the brands Thermo Scientific™, Applied Biosystems™, Invitrogen™, Gibco™, Ion Torrent™, Unity Lab Services™, Fisher Scientific™. I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com. By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Thermo Fisher Scientific Privacy Policy.

Top Stories

CSPM Buyers Guide

Google Cloud Security Foundations for Dummies

Security Leaders Handbook: The Strategic Guide to Cloud Security

Stay Connected

Scaling Non-Viral Cell Therapy Approaches for Solid Tumor Treatments

Fill out the form below to watch the webinar

Quick Links

About US